• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS OPERATIONS INC. COAGUCHEK XS PT TEST STRIPS; TEST, TIME, PROTHROMBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS OPERATIONS INC. COAGUCHEK XS PT TEST STRIPS; TEST, TIME, PROTHROMBIN Back to Search Results
Device Problem Nonstandard Device (1420)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
This is a complaint about how a class 1 fda recall was handled by my health care provider.The fda recall handling i am reporting is the "roche diagnostics to replace coagucheks xs pt test strips" and is listed at https://www.Fda.Gov/safety/recalls/ucm626140.Htm.On that page it states "action required - health care providers: advise your self-testing pts to do the same." the mfr is roche diagnostics and my health care provider is (b)(6).I am a pt of (b)(6) and use a device listed in the recall.The recall date is listed as 10/31/2018 on the fda site: https:www.Fda.Gov/safety/recalls/.I was however not notified about the recall.I was made aware of the recall later when reporting a test result to (b)(6) on (b)(6) 2019.I have tried to get clear info from (b)(6) about why i was not timely and properly notified but have been met with conflicting and changing stories.In addition to email/online messages, i have had conversations with (b)(6) manager of anti-coagulation care service in (b)(6), and (b)(6) regional clinical services mgr, pharmacy, (b)(6) region.When requesting info from (b)(6) about why i was not notified about the recall, i was initially told by (b)(6) that they had sent me a letter notifying me about the recall.When requesting to get the info in writing, (b)(6) then changed their story and stated that they had in fact not sent me a letter - that a mistake had been made.When i voiced concern about other pts potentially also not being notified i was then told by (b)(6) that i was the only pt that had not been notified - all other pts had been sent a letter.I find (b)(6) handling of the class 1 fda recall worrying and peculiar in that they claim all of their pts were notified except one; worrying because they are changing that story about when and how i was and was not notified.This seems to indicate that (b)(6) either have no process in place or the process is insufficient to properly handle fda recalls.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST STRIPS
Type of Device
TEST, TIME, PROTHROMBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS OPERATIONS INC.
MDR Report Key8509051
MDR Text Key141968536
Report NumberMW5085808
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/11/2019
Type of Device Usage N
Patient Sequence Number1
-
-